Fulgent Genetics, Inc. (FLGT) Stock Overview
Explore Fulgent Genetics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Fulgent Genetics, Inc. (FLGT)
Key Financials
Key Financials
Market Cap
718M
P/E Ratio
-8.19
EPS (TTM)
$0.01
ROE
-0.09%
FLGT Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Fulgent Genetics, Inc. (NASDAQ: FLGT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Fulgent Genetics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of FLGT on the NASDAQ shows an RSI of 68.35, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $25.44 for the NASDAQ listing.
Key metrics behind Fulgent Genetics, Inc.'s NASDAQ-traded stock include a P/E ratio of -8.19 and a market capitalization of 718M. Combined with our AI analysis, these give both institutional and retail investors a clear view of FLGT on the NASDAQ.